Maria Lúcia Lisbôa

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM To determine the relationship between macular thickness (MT) and visual field (VF) parameters, as well as with changes in the retinal nerve fiber layer (RNFL) thickness in patients with glaucoma and ocular hypertension (OH). MATERIALS AND METHODS Cross-sectional statistical analysis of spectral domain optical coherence tomography (SD-OCT) compared(More)
OBJECTIVE To report the clinical presentation of malarial retinopathy in an adult, emphasizing the importance of this diagnosis for the clinical suspicion and prognosis of cerebral malaria. METHODS A 39-year-old caucasian man presented with hemolytic anemia, thrombocytopenia, acidemia and acute renal failure, developing severe encephalopathy. The(More)
PURPOSE To describe a clinical case and literature review of Whipple disease. METHODS A 65-year-old male with bilateral decreased visual acuity for 3 weeks as well as bilateral hypoacusia, vertigo, disequilibrium, headache and decreased strength in the right upper limb for 4 months. The clinical work-up revealed a bilateral panuveitis and an ischemic(More)
SUMMARY Brain aging and dementia It is common knowledge that the base of the demographic pyramide is turning upwards as a consequence of the constant growing of the elderly population. This phenomenon worries everybody from families to government agencies. As a consequence, neuroscientists have been asked to cooperate for a better understanding of the(More)
A benign syndrome of acute ophthalmoplegia, ataxia, and arreflexia is commonly known as the Miller Fisher syndrome. It is generally believed that MilIer Fisher syndrome is a type of Guil lain-Barré syndrome, but several authors believe it to be a separate clinical entity caused by a cen tral nervous system lesion. Eight patients with MilIer Fisher syndrome(More)
Selective serotonin reuptake inhibitors (SSRI) are nowadays the preferred treatment for patients with depression and anxiety disorders, when compared with traditional tricyclic antidepressants. All the SSRIs were designed to selectively potentiate serotonin [5-hydroxytryptamine (5-HT)] activity through inhibition of the 5 –HT neuronal reuptake transporter.(More)
  • 1